Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 130

Similar articles for PubMed (Select 1729620)

1.

Seroprevalence of HTLV-1 and HTLV-2 among intravenous drug users and persons in clinics for sexually transmitted diseases.

Khabbaz RF, Onorato IM, Cannon RO, Hartley TM, Roberts B, Hosein B, Kaplan JE.

N Engl J Med. 1992 Feb 6;326(6):375-80.

2.

Seroprevalence of human T-lymphotropic virus type I or II in sexually transmitted disease clinic patients in the USA.

Khabbaz RF, Douglas JM Jr, Judson FN, Spiegel RA, St Louis ME, Whittington W, Hartley TM, Lairmore M, Kaplan JE.

J Infect Dis. 1990 Jul;162(1):241-4.

PMID:
2192006
3.

[Sero-epidemiological study on the human T-cell leukaemia virus type I/II infection in the east coastal areas of Fujian province].

Wang HR, Yan YS, Zhang QW, Zheng J, Liu JM, Feng YY, Wu SQ, Wu JH.

Zhonghua Liu Xing Bing Xue Za Zhi. 2004 May;25(5):428-30. Chinese.

PMID:
15231172
4.
5.

Infection with human T lymphotropic virus types I and II in sexually transmitted disease clinics in Baltimore and New Orleans.

Wiktor SZ, Cannon RO, Atkinson WL, Lutz B, Hook EW 3rd, Blattner WA, Quinn TC.

J Infect Dis. 1992 May;165(5):920-4.

PMID:
1569344
6.

Seroprevalence of human T cell lymphotropic virus type II infection, with or without human immunodeficiency virus type 1 coinfection, among US intravenous drug users.

Briggs NC, Battjes RJ, Cantor KP, Blattner WA, Yellin FM, Wilson S, Ritz AL, Weiss SH, Goedert JJ.

J Infect Dis. 1995 Jul;172(1):51-8.

PMID:
7797946
7.

Prevalence of HTLV types I and II among drug users in King County, Washington.

Thiede H, Harris NV, McGough JP, Roberts B, Khabbaz RF, Kaplan JE.

West J Med. 1994 Jun;160(6):540-4.

8.

HTLV infection in a group of prostitutes and their male sexual clients in Brazil: seroprevalence and risk factors.

Bellei NC, Granato CF, Tomyiama H, Castelo A, Ferreira O.

Trans R Soc Trop Med Hyg. 1996 Mar-Apr;90(2):122-5.

PMID:
8761567
9.

Human T-lymphotropic virus (HTLV I-II) infection among patients in an inner-city emergency department.

Kelen GD, DiGiovanna TA, Lofy L, Junkins E, Stein A, Sivertson KT, Lairmore M, Quinn TC.

Ann Intern Med. 1990 Sep 1;113(5):368-72.

PMID:
2382919
10.

Patterns of HIV-1 and HTLV-I/II in intravenous drug abusers from the middle atlantic and central regions of the USA.

Lee HH, Weiss SH, Brown LS, Mildvan D, Shorty V, Saravolatz L, Chu A, Ginzburg HM, Markowitz N, Des Jarlais DC, et al.

J Infect Dis. 1990 Aug;162(2):347-52.

PMID:
2373871
11.
12.

Human T lymphotropic virus type II (HTLV-II) infection in a cohort of New York intravenous drug users: an old infection?

Khabbaz RF, Hartel D, Lairmore M, Horsburgh CR, Schoenbaum EE, Roberts B, Hartley TM, Friedland G.

J Infect Dis. 1991 Feb;163(2):252-6.

PMID:
1988509
13.

Seroprevalence of HTLV-I and HTLV-II among a cohort of HIV-infected women and women at risk for HIV infection. Women's Interagency HIV Study.

Telzak EE, Hershow R, Kalish LA, Hardy WD Jr, Zuckerman E, Levine A, Delapenha R, DeHovitz J, Greenblatt RM, Anastos K.

J Acquir Immune Defic Syndr Hum Retrovirol. 1998 Dec 15;19(5):513-8.

PMID:
9859966
14.

Seroepidemiology of viral infections among intravenous drug users in northern California.

Zeldis JB, Jain S, Kuramoto IK, Richards C, Sazama K, Samuels S, Holland PV, Flynn N.

West J Med. 1992 Jan;156(1):30-5.

15.

Human T-cell lymphotropic virus types I and II infections in patients with leukaemia/lymphoma and in subjects with sexually transmitted diseases in Nigeria.

Olaleye OD, Ekweozor CC, Li ZL, Opala IE, Sheng Z, Onyemenem TN, Rasheed S.

Arch Virol. 1996;141(2):345-55.

PMID:
8634025
16.

HTLV-I/II seroprevalence and HIV/HTLV coinfection among U.S. intravenous drug users.

Cantor KP, Weiss SH, Goedert JJ, Battjes RJ.

J Acquir Immune Defic Syndr. 1991;4(5):460-7.

PMID:
2016683
17.

Human T-lymphotropic virus type II seroprevalence among emergency department and clinic patients.

Agranoff D, Varney K, Khayam-Bashi H, Murphy EL.

West J Med. 1996 Jun;164(6):481-5.

18.

Human T cell lymphotropic virus types I and II in intravenous drug users in San Francisco: risk factors associated with seropositivity.

Feigal E, Murphy E, Vranizan K, Bacchetti P, Chaisson R, Drummond JE, Blattner W, McGrath M, Greenspan J, Moss A.

J Infect Dis. 1991 Jul;164(1):36-42.

PMID:
2056217
19.

Seroprevalence of HTLV-I/II and HIV-1 infection among male intravenous drug abusers in Chicago.

Lentino JR, Pachucki CT, Schaaff DM, Schaefer MR, Holzer TJ, Heynen C, Dawson G, Dorus W.

J Acquir Immune Defic Syndr. 1991;4(9):901-9.

PMID:
1895212
20.

HTLV-I and HTLV-II infections among HIV-1 seropositive patients in Sao Paulo, Brazil.

de Araujo AC, Casseb JS, Neitzert E, de Souza ML, Mammano F, Del Mistro A, De Rossi A, Chieco-Bianchi L.

Eur J Epidemiol. 1994 Apr;10(2):165-71.

PMID:
7813694
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk